PROMIS NEUROSCIENCES
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-02-10
2025-02-12
CASHMAN NEIL
Chief Scientific Officer
P - Purchase
Common Shares
15,000
$1.00
15,000
1
$16.34M
2024-11-18
2024-11-20
ALTSTIEL LARRY DOUGLAS
Chief Medical Officer
A - Grant
Option (right to buy)
175K
$0.00
1
$16.34M
2024-11-18
2024-11-20
CASHMAN NEIL
Chief Scientific Officer
A - Grant
Option (right to buy)
200K
$0.00
1
$16.34M
2024-11-18
2024-11-20
KAPLAN JOHANNE
Chief Development Officer
A - Grant
Option (right to buy)
175K
$0.00
1
$16.34M
2024-11-18
2024-11-20
MILBURY MAX
Principal Accounting Officer
A - Grant
Option (right to buy)
70,000
$0.00
1
$16.34M
2024-10-08
2024-10-10
WARMA NEIL
Chief Executive Officer
A - Grant
Option (right to buy)
1.63M
$0.00
2
$16.34M
2024-09-17
2024-09-18
GORDON MICHAEL
P - Purchase
Common Shares, no par value
16,292
$1.00
16,292
1
$16.34M
2024-09-16
2024-09-18
GORDON MICHAEL
P - Purchase
Common Shares, no par value
76,931
$1.00
76,931
1
$16.34M
2024-07-31
2024-08-02
GORDON MICHAEL
C - Conversion
Series 2 Preferred Shares, no par value
-500K
1
$16.34M
2024-07-31
2024-08-02
SCLAR JEREMY
C - Conversion
Series 2 Preferred Shares, no par value
-300K
2
$16.34M
2024-07-31
2024-08-02
TITLE 19 PROMIS
C - Conversion
Series 2 Preferred Shares, no par value
-500K
1
$16.34M
2024-07-31
2024-08-02
GORDON MICHAEL
P - Purchase
Tranche A Common Share Purchase Warrants
465K
1
$16.34M
2024-07-31
2024-08-02
GORDON MICHAEL
P - Purchase
Tranche B Common Share Purchase Warrants
465K
1
$16.34M
2024-07-31
2024-08-02
GORDON MICHAEL
P - Purchase
Tranche C Common Share Purchase Warrants
465K
1
$16.34M
2024-07-31
2024-08-02
TITLE 19 PROMIS
P - Purchase
Tranche A Common Share Purchase Warrants
465K
1
$16.34M
2024-07-31
2024-08-02
TITLE 19 PROMIS
P - Purchase
Tranche B Common Share Purchase Warrants
465K
1
$16.34M
2024-07-31
2024-08-02
TITLE 19 PROMIS
P - Purchase
Tranche C Common Share Purchase Warrants
465K
1
$16.34M
2024-01-02
2024-01-05
WARMA NEIL
Chief Executive Officer
A - Grant
Option (right to buy)
200K
$0.00
1
$16.34M
2022-10-11
2024-01-02
SCLAR JEREMY
P - Purchase
Warrants to Purchase Common Shares, no par value
26,217
1
$16.34M
2023-10-26
2023-10-30
KAPLAN JOHANNE
Chief Development Officer
A - Grant
Option (right to buy)
12,500
$0.00
1
$16.34M
2023-10-26
2023-10-30
MALENFANT GAVIN
Chief Operating Officer
A - Grant
Option (right to buy)
12,500
$0.00
1
$16.34M
2023-10-26
2023-10-30
MILBURY MAX
Principal Accounting Officer
A - Grant
Option (right to buy)
12,500
$0.00
1
$16.34M
2023-10-26
2023-10-30
ALTSTIEL LARRY DOUGLAS
Chief Medical Officer
A - Grant
Option (right to buy)
12,500
$0.00
1
$16.34M
2023-10-26
2023-10-30
CASHMAN NEIL
Chief Scientific Officer
A - Grant
Option (right to buy)
12,500
$0.00
1
$16.34M
2023-10-26
2023-10-30
GEFFKEN DANIEL
Chief Financial Officer
A - Grant
Option (right to buy)
2,500
$0.00
1
$16.34M
2023-08-23
2023-08-25
MILBURY MAX
Principal Accounting Officer
A - Grant
Warrants to purchase Common Shares
13,297
1
$16.34M
2023-08-23
2023-08-25
FARFEL GAIL
Chief Executive Officer
A - Grant
Warrants to purchase Common Shares
53,192
1
$16.34M
2023-08-23
2023-08-25
MALENFANT GAVIN
Chief Operating Officer
A - Grant
Warrants to purchase Common Shares
2,660
1
$16.34M
2023-08-23
2023-08-25
CASHMAN NEIL
Chief Scientific Officer
A - Grant
Warrants to purchase Common Shares
10,643
1
$16.34M
2022-12-14
2022-12-16
FARFEL GAIL
Chief Executive Officer
P - Purchase
Common Shares
1,000
$5.00
5,000
1
$16.34M
2022-12-06
2022-12-08
FARFEL GAIL
Chief Executive Officer
P - Purchase
Common Share
1,000
$6.00
6,000
1
$16.34M
2022-09-19
2022-09-20
FARFEL GAIL
Chief Executive Officer
A - Grant
Option (right to buy)
208K
$0.00
1
$16.34M
2022-07-11
2022-07-12
WILLIAMS EUGENE
Chairman and CEO
P - Purchase
Common Shares
1,000
$10.00
10,000
1
$16.34M